ZNF134
geneOn this page
Also known as pHZ-15
Summary
ZNF134 (zinc finger protein 134, HGNC:12918) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 134 (P52741). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II; regulation of cytokine production; and regulation of immune system process. Located in nucleoplasm.
Source: NCBI Gene 7693 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 71 total
- MANE Select transcript:
NM_003435
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12918 |
| Approved symbol | ZNF134 |
| Name | zinc finger protein 134 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | pHZ-15 |
| Ensembl gene | ENSG00000213762 |
| Ensembl biotype | protein_coding |
| OMIM | 604076 |
| Entrez | 7693 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000396161, ENST00000597975, ENST00000600344, ENST00000600883, ENST00000948622
RefSeq mRNA: 1 — MANE Select: NM_003435
NM_003435
CCDS: CCDS42638
Canonical transcript exons
ENST00000396161 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001524097 | 57620160 | 57624724 |
| ENSE00002689514 | 57619412 | 57619508 |
| ENSE00003226314 | 57614242 | 57614503 |
Expression profiles
Bgee: expression breadth ubiquitous, 245 present calls, max score 87.31.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 17.1080 / max 178.7572, expressed in 1801 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177785 | 17.1080 | 1801 |
Top tissues by expression
280 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.31 | gold quality |
| secondary oocyte | CL:0000655 | 86.72 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.21 | gold quality |
| cortical plate | UBERON:0005343 | 84.76 | gold quality |
| ganglionic eminence | UBERON:0004023 | 84.71 | gold quality |
| ventricular zone | UBERON:0003053 | 84.08 | gold quality |
| oocyte | CL:0000023 | 84.05 | gold quality |
| embryo | UBERON:0000922 | 83.31 | gold quality |
| colonic epithelium | UBERON:0000397 | 80.79 | gold quality |
| adrenal tissue | UBERON:0018303 | 80.52 | gold quality |
| calcaneal tendon | UBERON:0003701 | 80.19 | gold quality |
| islet of Langerhans | UBERON:0000006 | 80.16 | gold quality |
| cerebellar cortex | UBERON:0002129 | 79.90 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 79.88 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 79.77 | gold quality |
| stromal cell of endometrium | CL:0002255 | 79.28 | gold quality |
| buccal mucosa cell | CL:0002336 | 79.26 | silver quality |
| cerebellum | UBERON:0002037 | 78.80 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 78.66 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 78.60 | gold quality |
| lower esophagus | UBERON:0013473 | 78.59 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 78.04 | gold quality |
| gastrocnemius | UBERON:0001388 | 78.03 | gold quality |
| muscle of leg | UBERON:0001383 | 77.93 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 77.93 | gold quality |
| heart left ventricle | UBERON:0002084 | 77.83 | gold quality |
| skin of abdomen | UBERON:0001416 | 77.78 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 77.70 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 77.59 | gold quality |
| cardiac ventricle | UBERON:0002082 | 77.53 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.72 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| CDKN2A |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2491.1 | ZNF134 | Factors with multiple dispersed zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605530
miRNA regulators (miRDB)
114 targeting ZNF134, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-767-5P | 99.95 | 70.85 | 993 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-6515-3P | 99.82 | 68.19 | 1933 |
| HSA-MIR-609 | 99.82 | 64.26 | 505 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-4694-3P | 99.79 | 69.53 | 2640 |
| HSA-MIR-4668-5P | 99.79 | 70.58 | 3782 |
| HSA-MIR-6817-3P | 99.79 | 68.35 | 2126 |
| HSA-MIR-200A-5P | 99.76 | 69.10 | 949 |
| HSA-MIR-498-5P | 99.76 | 69.64 | 1807 |
| HSA-MIR-3913-3P | 99.74 | 66.53 | 938 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-4446-5P | 99.72 | 69.19 | 2544 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zfx | ENSDARG00000074453 |
| danio_rerio | ENSDARG00000098424 | |
| mus_musculus | Zfy2 | ENSMUSG00000000103 |
| mus_musculus | Zfy1 | ENSMUSG00000053211 |
| rattus_norvegicus | Zfy1 | ENSRNOG00000053042 |
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)
Protein
Protein identifiers
Zinc finger protein 134 — P52741 (reviewed: P52741)
All UniProt accessions (3): P52741, M0QXC7, M0R246
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P52741-1 | 1 | yes |
| P52741-2 | 2 |
RefSeq proteins (1): NP_003426* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050826 | Krueppel_C2H2_ZnFinger | Family |
Pfam: PF00096
UniProt features (19 total): zinc finger region 11, cross-link 3, sequence variant 3, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P52741-F1 | 66.14 | 0.34 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 20, 135, 139
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 103 (showing top):
MORF_MSH3, MORF_BRCA1, MORF_ESR1, MORF_RAD51L3, GCM_RING1, GOBP_CYTOKINE_PRODUCTION, MORF_ATF2, DANG_BOUND_BY_MYC, MORF_BCL2L11, MORF_PPP2R5B, GCM_VAV1, MORF_PTEN, BENPORATH_MYC_MAX_TARGETS, STEIN_ESRRA_TARGETS_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING
GO Biological Process (3): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of cytokine production (GO:0001817), regulation of immune system process (GO:0002682)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleoplasm (GO:0005654), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| cytokine production | 1 |
| regulation of gene expression | 1 |
| regulation of multicellular organismal process | 1 |
| immune system process | 1 |
| regulation of biological process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
504 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF134 | FAXDC2 | Q96IV6 | 576 |
| ZNF134 | COPZ1 | P61923 | 507 |
| ZNF134 | SLC14A1 | Q13336 | 507 |
| ZNF134 | TSPYL4 | Q9UJ04 | 479 |
| ZNF134 | EFTUD2 | Q15029 | 434 |
| ZNF134 | MAP4K1 | Q92918 | 418 |
| ZNF134 | ZNF45 | P17016 | 414 |
| ZNF134 | K7ESF6 | K7ESF6 | 414 |
| ZNF134 | ZNF44 | P15621 | 406 |
| ZNF134 | ZNF629 | Q9UEG4 | 394 |
| ZNF134 | ZNF436 | Q9C0F3 | 393 |
| ZNF134 | ZNF569 | Q5MCW4 | 393 |
| ZNF134 | MAGEB2 | O15479 | 392 |
| ZNF134 | EPHX3 | Q9H6B9 | 391 |
| ZNF134 | ZNF501 | Q96CX3 | 384 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MFAP1 | ZNF134 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TNS2 | ZNF134 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF134 | MFAP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF134 | TNS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF134 | TRIM41 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF134 | psi-mi:“MI:0915”(physical association) | 0.370 | |
| TRIM41 | ZNF134 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (2): ZNF134 (Two-hybrid), ZNF134 (Two-hybrid)
ESM2 similar proteins: A0JNB1, A1YF12, A1YG88, A2T759, B2RUI1, O43296, O75123, P10072, P17020, P17021, P17097, P51814, P52740, P52741, Q07230, Q08ER8, Q13398, Q14590, Q32KN0, Q3KQV3, Q3MIS6, Q4V8A8, Q5CZA5, Q5RBQ3, Q5RBX0, Q5RCD9, Q5RCX4, Q6GQR8, Q6NX45, Q6P9A3, Q6PK81, Q7TSH9, Q7TSI0, Q7Z7L9, Q86UD4, Q8BFS8, Q8BLB0, Q8IVP9, Q8IZ26, Q8TAU3
Diamond homologs: A2VDP4, B7Z6K7, D3ZVT0, E7ETH6, E9Q8G5, O43296, O43361, O75290, O75467, O75820, P0CH99, P0CI00, P15621, P17021, P17023, P17024, P17030, P17032, P52740, P52741, Q02525, Q06732, Q08DG8, Q08ER8, Q0VCB0, Q13106, Q13398, Q14587, Q147U1, Q15935, Q2M218, Q2M3X9, Q32M78, Q3KQV3, Q3SY52, Q3V080, Q3ZCX4, Q4R882, Q4V8A8, Q5CZA5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
71 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 60 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
520 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:57614499:CGCAG:C | donor_loss | 0.9900 |
| 19:57614501:CAG:C | donor_loss | 0.9900 |
| 19:57614502:AG:A | donor_loss | 0.9900 |
| 19:57614503:GG:G | donor_loss | 0.9900 |
| 19:57614504:GT:G | donor_loss | 0.9900 |
| 19:57614505:T:G | donor_loss | 0.9900 |
| 19:57614456:G:GA | donor_gain | 0.9700 |
| 19:57614455:T:TA | donor_gain | 0.9500 |
| 19:57624292:A:T | acceptor_gain | 0.9500 |
| 19:57614489:A:AG | donor_gain | 0.9300 |
| 19:57614605:G:GT | donor_gain | 0.9100 |
| 19:57614504:G:GG | donor_gain | 0.9000 |
| 19:57624293:G:T | acceptor_gain | 0.8800 |
| 19:57614939:G:GA | donor_gain | 0.8700 |
| 19:57614500:GCAG:G | donor_gain | 0.8600 |
| 19:57614904:G:GT | donor_gain | 0.8500 |
| 19:57614926:G:GT | donor_gain | 0.8400 |
| 19:57614471:A:AG | donor_gain | 0.8100 |
| 19:57614606:C:T | donor_gain | 0.8100 |
| 19:57614622:G:A | donor_gain | 0.8000 |
| 19:57624291:TA:T | acceptor_gain | 0.7900 |
| 19:57614938:T:TA | donor_gain | 0.7700 |
| 19:57620154:CTTCA:C | acceptor_loss | 0.7700 |
| 19:57620155:TTCA:T | acceptor_loss | 0.7700 |
| 19:57620156:TCAGG:T | acceptor_loss | 0.7700 |
| 19:57620157:CAGGT:C | acceptor_loss | 0.7700 |
| 19:57620158:A:T | acceptor_loss | 0.7700 |
| 19:57620159:G:GC | acceptor_loss | 0.7700 |
| 19:57620151:T:A | acceptor_loss | 0.7600 |
| 19:57620144:ATTTT:A | acceptor_loss | 0.7400 |
AlphaMissense
2878 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:57620756:T:C | F213L | 0.998 |
| 19:57620758:C:A | F213L | 0.998 |
| 19:57620758:C:G | F213L | 0.998 |
| 19:57620840:T:C | F241L | 0.997 |
| 19:57620842:C:A | F241L | 0.997 |
| 19:57620842:C:G | F241L | 0.997 |
| 19:57620847:G:C | R243P | 0.997 |
| 19:57621260:T:C | F381L | 0.997 |
| 19:57621262:T:A | F381L | 0.997 |
| 19:57621262:T:G | F381L | 0.997 |
| 19:57620672:T:C | F185L | 0.996 |
| 19:57620674:C:A | F185L | 0.996 |
| 19:57620674:C:G | F185L | 0.996 |
| 19:57620763:G:C | R215P | 0.996 |
| 19:57621008:T:C | F297L | 0.996 |
| 19:57621010:C:A | F297L | 0.996 |
| 19:57621010:C:G | F297L | 0.996 |
| 19:57621092:T:C | F325L | 0.996 |
| 19:57621094:T:A | F325L | 0.996 |
| 19:57621094:T:G | F325L | 0.996 |
| 19:57621279:T:C | L387P | 0.996 |
| 19:57620785:T:A | H222Q | 0.995 |
| 19:57620785:T:G | H222Q | 0.995 |
| 19:57620787:A:C | Q223P | 0.995 |
| 19:57620859:T:C | L247P | 0.995 |
| 19:57620924:T:C | F269L | 0.995 |
| 19:57620926:T:A | F269L | 0.995 |
| 19:57620926:T:G | F269L | 0.995 |
| 19:57620943:T:C | L275P | 0.995 |
| 19:57621291:A:C | Q391P | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000788055 (19:57617310 G>A), RS1000806093 (19:57621306 G>A,T), RS1000923773 (19:57617049 C>T), RS1000943843 (19:57623547 GAAA>G,GAA,GAAAA), RS1001007071 (19:57615675 C>T), RS1001124470 (19:57619153 A>G), RS1001345612 (19:57616983 T>C), RS1001473328 (19:57616703 G>A), RS1001479425 (19:57623188 A>G), RS1001629097 (19:57624405 C>T), RS1002649293 (19:57614278 C>A,T), RS1002788436 (19:57617725 T>C), RS1002795026 (19:57620003 AGTACT>A), RS1003092054 (19:57617443 A>G), RS1003684866 (19:57613552 C>T)
Disease associations
OMIM: gene MIM:604076 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST011383_20 | Mastocytosis | 6.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB clinical annotations
1 annotations.
| Variant | Type | Level | Drugs | Phenotypes |
|---|---|---|---|---|
| rs10413455 | Efficacy | 3 | methylphenidate | Attention Deficit Disorder with Hyperactivity |
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs10413455 | ZNF134 | 3 | 0.00 | 1 | methylphenidate |
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases abundance, increases expression | 2 |
| Smoke | decreases expression, increases abundance | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| urushiol | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | increases expression | 1 |
| geraniol | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| manganese chloride | increases expression, increases abundance | 1 |
| abrine | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Coal | decreases expression, increases abundance | 1 |
| Doxorubicin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Testosterone | increases expression | 1 |
| Sodium Selenite | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): mastocytosis